文摘
Metabotropic glutamate receptor 1 (mGluR1) plays importantroles in the neurotransmission and pathogenesis of several neurologicaldisorders, including chronic pain. Antagonists of mGlur1 are suggestedto be useful for the treatment of pain. Herein, we report the discoveryof a novel series of tetracyclic mGluR1 antagonists, such as 23c and23e, with oral efficacy of ED50 of 8 and 5.1 mg/kg, respectively, in ratspinal nerve ligation neuropathic pain model.